ADME and Drug-Drug Interaction Considerations During Drug Development

DATE

May 18, 2022

TIME

8:00 a.m. PDT, 11:00 a.m. EDT, 16:00 BST, 17:00 CEST

Duration: 60 Minutes

Overview

In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making. This webinar will provide insights at a high-level related to regulatory drivers, investigatory objectives, and practical concerns for such studies.

Participants will gain insight into the critical need and utility for in vitro ADME and DDI investigations in the drug development process. Regulatory expectations will be reviewed as will points of particular interest for enabling successful achievement of investigatory goals.

Key Learning Objectives:

Why run these studies?
Predominant types of in vitro ADME & DDI studies
When to conduct these studies
Areas of concern: Proper design & interpretation
And other highlights and information…

Who Should Attend:

Research scientists
Drug development leadership
Anyone aiming for successful IND / NDA submission
Needing to meet regulatory requests and expectations
Desiring to formulate a development plan that is as efficient and cost-effective as possible and mitigates risks of late stage failure
Simply wanting to better understand the ADME properties and potential DDI risks of their compound

Brought to you by:

Speakers

Dr. Pallavi Limaye
Director of Scientific Consulting
SEKISUI XenoTech

Ann Thayer
Contributing Editor,
C&EN Media Group

Registration

Forwarded this event? Clear the form

Email Address*

Salutation

First Name*

Last Name*

Company*

Job Title*

Address 1*

City*

State*

Zip / Post Code*

Country*

Business Phone*

How are you involved with ADME &/or DDI evaluation?*

What are you hoping to gain from this webinar?*

I would like to receive more information on products and services from the American Chemical Society

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

View On Demand Webinars